Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson's disease from essential tremor

Journal of Neural Transmission

Volumn 114, Issue 7, 2007, Pages 935-938

  Pellicano, C ^a   Buttarelli, F R ^a   Circella, A ^b   Tiple, D ^a   Giovannelli, M ^a   Benincasa, D ^a   Colosimo, C ^a   Pontieri, F E ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

Dopamine transporter; Essential tremor; Lymphocytes; Parkinson's disease

Indexed keywords

DOPAMINE TRANSPORTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DOPAMINERGIC ACTIVITY; ESSENTIAL TREMOR; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; PARKINSON DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; DIAGNOSIS, DIFFERENTIAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ESSENTIAL TREMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 34347345956     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0623-2     Document Type: Article

References (24)

1. F Amenta E Bronzetti F Cantalamessa D El-Assouad L Felici A Ricci SK Tayebati 2001 Identification of dopamine plasma membrane and vesiculars transporters in human peripheral blood lymphocytes J Neuroimmunol 117 133 142
2. MJ Bannon CJ Whitty 1997 Age-related and regional differences in dopamine transporter mRNA expression in human midbrain Neurology 48 969 977
3. P Barbanti G Fabbrini A Ricci R Cerbo E Bronzetti B Caronti C Calderaro L Felici F Stocchi G Meco F Amenta GL Lenzi 1999 Increased expression of dopamine receptors on lymphocytes in Parkinson's disease Mov Disord 14 764 771
4. E Bartha J Szelenyi K Szilagyi V Venter NT Thu Ha P Paldi-Haris S Hollan 1987 Altered lymphocyte acetylcholinesterase activity in patients with senile dementia Neurosci Lett 79 190 194
5. 123I]-FP-CIT study group Mov Disord 15 503 510
6. GD Borasio R Linke J Schwarz V Schlamp A Abel PD Mozley K Tatsch 1998 Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography J Neurol Neurosurg Psychiatry 65 263 265
7. FR Buttarelli A Circella C Pellicano FE Pontieri 2006 Dopamine transporter immunoreactivity in peripheral blood mononuclear cells in amyotrophic lateral sclerosis Eur J Neurol 13 416 418
8. B Caronti G Tanda C Colosimo S Ruggieri C Calderaro G Palladini FE Pontieri G Di Chiara 1999 Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease Neuro Report 10 2907 2910
9. B Caronti G Antonini C Calderaro S Ruggieri G Palladini FE Pontieri C Colosimo 2001 Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease J Neural Transm 108 803 807
10. G Deuschl P Bain M Brin 1998 Consensus statement of the Movement Disorder Society on tremor Ad hoc Scientific Committee. Mov Disord 3 Suppl 3 2 23
11. F Giubilei C Calderaro G Antonini M Sepe-Monti P Tisei E Brunetti F Marchione B Caronti FE Pontieri 2004 Increased lymphocyte dopamine beta-hydroxylase immunoreactivity in Alzheimer's disease: compensatory response to cholinergic deficit? Dement Geriatr Cogn Disord 18 338 341
12. KA Harrington SJ Augood AE Kingsbury OJ Foster PC Emson 1996 Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease Mol Brain Res 36 157 162
13. MM Hoehn MD Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442
14. AJ Hughes SE Daniel L Kilford AJ Lees 1992 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184
15. NC Inestrosa R Alarcon J Arriagada A Donoso J Alvarez EO Campos 1994 Blood markers in Alzheimer disease: subnormal acetylcholinesterase and butyrylcholinesterase in lymphocytes and erythrocytes J Neurol Sci 122 1 5
16. JN Joyce G Smutzer CJ Whitty A Myers MJ Bannon 1997 Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease Mov Disord 12 885 897
17. S Kato M Oda H Tanabe 1993 Diminution of dopaminergic neurons in the substantia nigra in sporadic amyotrophic lateral sclerosis Neuropathol Appl Neurobiol 19 300 304
18. 123I]-beta-CIT-SPECT imaging assessment of the rate of Parkinson's disease progression Neurology 57 2089 2094
19. Y Nagai S Ueno Y Saeki F Soga M Hirano T Yanagihara 1996 Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease Neurology 46 791 795
20. C Raida G Dibo L Vecsei J Bergquist 2005 Increased dopamine content in lymphocytes from high-dose L-dopa-treated Parkinson's disease patients Neuroimmunomodulation 12 81 84
21. MK Sanghera KF Manaye CL Liang AM Iacopino MJ Bannon DC German 1994 Low dopamine transporter mRNA levels in midbrain regions containing calbindin Neuro Report 5 1641 1644
22. 123I]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis Arch Neurol 57 205 208
23. GR Uhl 1998 Hypothesis: the role of dopamine transporter in selective vulnerability of cells on Parkinson's disease Ann Neurol 43 555 560
24. GR Uhl D Walter D Mash B Faucheux F Javoy-Agid 1994 Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons Ann Neurol 35 494 498